|Articles|November 16, 2011
- The Column-11-16-2011
- Volume 7
- Issue 21
Perfecting Processes in Drug Discovery
Author(s)Frederic Cheviron
Janet Kelsey of The Column spoke to Frédéric Cheviron, Sales & Marketing Manager for Chiral Technologies Europe, about the technology they use in drug development and how companies can improve their method development.
Advertisement
Janet Kelsey of The Column spoke to Frédéric Cheviron, Sales & Marketing Manager for Chiral Technologies Europe, about the technology they use in drug development and how companies can improve their method development.
Articles in this issue
about 14 years ago
Drug Discovery Advances Inextricably Linked to Specialty Gasesabout 14 years ago
Flow splitting to improve peak capacity in on-line LC×LCabout 14 years ago
The 'Inverse Van Gogh' Syndromeabout 14 years ago
Silky datingabout 14 years ago
Bird-brained molecular sexingabout 14 years ago
Sweet sweet cornNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
3
Dr. Rigoberto Advincula on Advancing Polymer Research With Py-GC/MS
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5